Trials / Conditions / Lymphoma, Intermediate-Grade
Lymphoma, Intermediate-Grade
3 registered clinical trials studyying Lymphoma, Intermediate-Grade.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Ofatumumab In Older Patients With Untreated Low Or Intermediate Risk Indolent B-Cell Lymphomas NCT01263418 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Completed | Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL NCT00546793 | Gilead Sciences | Phase 1 / Phase 2 |
| Unknown | FCM Versus R-FCM Followed by R-Maintenance or Observation Only NCT00317096 | Ludwig-Maximilians - University of Munich | Phase 3 |